Thrombosis |
From the Thrombosis and Haemostasis Laboratory (E.d.D., G.G., H.v.d.V., J.D., C.K., J.-W.N.A.), Department of Haematology, University Medical Center Utrecht and Institute for Biomembranes, Utrecht University, Utrecht, and the Department of Biochemistry and Human Biology (J.W.M.H.), Maastricht University, Maastricht, The Netherlands, and the Department of Molecular Neurobiology (K.M.), Institute of Medical Science, Tokyo University, Tokyo, Japan.
Correspondence to Els den Dekker, Thrombosis and Haemostasis Laboratory, Department of Haematology, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. E-mail e.dendekker{at}lab.azu.nl
The immature megakaryoblastic cell line MEG-01 responds to iloprost with an increase in cytosolic Ca2+ and cAMP. The Ca2+ response is almost absent in CHRF-288-11 cells, but cAMP formation is preserved in this more mature megakaryoblastic cell line. Also, in human hematopoietic stem cells, iloprost induces a Ca2+ response and cAMP formation. The Ca2+ response is downregulated during megakaryocytopoiesis, but cAMP formation remains unchanged. The Ca2+ increase may be caused by cAMP-mediated inhibition of Ca2+ sequestration, because it is (1) independent of Ca2+ entry; (2) mimicked by forskolin, an activator of adenylyl cyclase, and isobutylmethylxanthine, an inhibitor of phosphodiesterases; and (3) preserved in the presence of inhibitors of protein kinase A and inositol-1,4,5-triphosphate receptors. The small GTPase Rap1 has been implicated in the control of Ca2+ sequestration. Indeed, Rap1 activation parallels the iloprost- and forskolin-induced Ca2+ increase and is unaffected by the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N',-tetraacetic acid-AM. These findings reveal a novel mechanism for elevating cytosolic Ca2+ by cAMP, possibly via GTP-Rap1.
Key Words: calcium cAMP stem cells megakaryocytes Rap1
This article has been cited by other articles:
![]() |
I. A. Ferreira, A. I.M. Mocking, M. A.H. Feijge, G. Gorter, T. W. van Haeften, J. W.M. Heemskerk, and J.-W. N. Akkerman Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Morel, A. Marcantoni, M. Gastineau, R. Birkedal, F. Rochais, A. Garnier, A.-M. Lompre, G. Vandecasteele, and F. Lezoualc'h cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy Circ. Res., December 9, 2005; 97(12): 1296 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Wagner II, W.-H. Li, and D. I. Yule Phosphorylation of Type-1 Inositol 1,4,5-Trisphosphate Receptors by Cyclic Nucleotide-dependent Protein Kinases: A MUTATIONAL ANALYSIS OF THE FUNCTIONALLY IMPORTANT SITES IN THE S2+ AND S2- SPLICE VARIANTS J. Biol. Chem., November 14, 2003; 278(46): 45811 - 45817. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. den Dekker, G. Gorter, J. W. M. Heemskerk, and J.-W. N. Akkerman Development of Platelet Inhibition by cAMP during Megakaryocytopoiesis J. Biol. Chem., August 2, 2002; 277(32): 29321 - 29329. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |